Y. Hong

发表

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study

E. Van Cutsem, H. Lenz, J. Stoehr, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer

Y. S. Kim, S. Roh, D. Cho, 2013, British Journal of Cancer.

Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus.

C. Cho, S. H. Lee, J. Min, 1997, The Journal of rheumatology.

A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer.

S. Song, H. Chung, J. Cho, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

The predictors of development of new syndesmophytes in female patients with ankylosing spondylitis

J. Ju, S. Park, K. Kang, 2015, Scandinavian journal of rheumatology.

Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery

J. H. Kim, C. Kang, Y. Hong, 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Incidence and Multiplicities of Adenomatous Polyps in TNM Stage I Colorectal Cancer in Korea

Gangmi Kim, S. Hong, E. Jung, 2012, Journal of the Korean Society of Coloproctology.

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC

E. Van Cutsem, J. Tabernero, R. Yaeger, 2022, ESMO open.

Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients

Y. Hong, S. Cho, J. Hahm, 2001, The British journal of dermatology.

Predictors of prescription of morphine for severe cancer pain by physicians in Korea.

Sue-Kyung Park, D. Heo, Y. Yun, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.

S. S. Lee, C. Cho, M. Cho, 2001, The Journal of rheumatology.

Review : Decreased tumour necrosis factor-beta production in TNFB*2 homozygote: an important predisposing factor of lupus nephritis in Koreans

Sang-Heon Lee, Ho‐Youn Kim, C. Cho, 1997, Lupus.

Quality of life (QOL) assessment of MIP (mitomycin, ifosfamide and cisplatin) chemotherapy in advanced non-small cell lung cancers (NSCLC).

J. Han, Y. Hong, K. S. Lee, 1998, Japanese journal of clinical oncology.

IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.

S. S. Lee, W. Park, Wan-Uk Kim, 2000, The Journal of rheumatology.

Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus.

S. Y. Yang, C. Cho, M. Cho, 2001, Scandinavian journal of rheumatology.

Impact of perception of socioeconomic burden on advocacy for patient autonomy in end-of-life decision making: a study of societal attitudes

D. Heo, J. H. Lee, D. W. Shin, 2009, Palliative medicine.

Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis.

S. S. Lee, C. Cho, M. Cho, 2000, The Journal of rheumatology.

Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer

J. H. Kim, E. Jwa, Y. Hong, 2014, British Journal of Cancer.

Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer

M. Ahn, S. C. Lee, I. Hwang, 2006, British Journal of Cancer.

INCB018424 induces apoptotic cell death through the suppression of pJAK1 in human colon cancer cells.

J. Moon, D. Jin, E. Choi, 2013, Neoplasma.

p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN

J. Moon, D. Jin, Y. Suh, 2013, Cell Death and Differentiation.

Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity

J. Shin, Hyeong-Seok Lim, M. Ryu, 2011, British Journal of Cancer.

BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer.

J. Desai, E. Van Cutsem, J. Tabernero, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Milademetan, an oral MDM2 inhibitor, in well-differentiated/ dedifferentiated liposarcoma: results from a phase 1 study in patients with solid tumors or lymphomas

P. LoRusso, G. Schwartz, M. Gounder, 2020 .

Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group.

Yoon-Koo Kang, D. Heo, Jun Suk Kim, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy and safety of cobimetinib (cobi) and atezolizumab (atezo) in an expanded phase 1b study of microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)

J. Desai, Y. Bang, E. Kwak, 2016 .

CpG island methylator phenotype and KRAS mutation status as prognostic markers in patients with resected colorectal cancer.

S. Jang, D. Koo, Y. Kang, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association between HER2 amplification and cetuximab efficacy in patients with RAS wild-type metastatic colorectal cancer

D. Kim, S. Kim, Juyang Kim, 2016 .

The impact of HLA-DRB1*0405 on disease severity in Korean patients with seropositive rheumatoid arthritis.

W. Jee, C. Cho, S. H. Lee, 1997, British journal of rheumatology.